Company 

Area

Exit

Acquirer /
Exchange

Acusphere

Drug development
Cardiovascular

IPO
2003

NASDAQ

Adnexus Therapeutics

Drug development
Oncology

Trade sale
2007

BMS

Agensys

Drug development
Oncology

Trade sale
2007

Astellas

Anadys Pharmaceuticals

Drug development
Anti-infectives / Oncology

IPO
2004

NASDAQ

Drug development
Cardiovascular / Inflammation

IPO
2010

NASDAQ

Arpida

Drug development
Anti-infectives

IPO
2005

SIX

Aspreva Pharmaceuticals

Drug development
Immunology

IPO
2005

NASDAQ

Axovan

Drug development
Cardiovascular

Trade sale
2004

Actelion

Basilea Pharmaceutica

Drug development
Anti-infectives

IPO
2004

SIX

Biovitrum

Drug development
Hematology / Metabolic

IPO
2006

OMX
Stockholm

Cardion

Drug development
Cardiovascular

Trade sale
2003

Roche

China Nuokang

Drug development
Cardiovascular

IPO
2009

NASDAQ

Corgentech

Drug development
Neurology

IPO
2004

NASDAQ

Cytokinetics

Drug development
Metabolic /Oncology

IPO
2004

NASDAQ

Cytos Biotechnology

Drug development
Immunology

IPO
2002

SIX

ESBATech

Drug development
Ophthalmology

Trade sale
2009

Alcon

Genesoft Pharmaceuticals.

Drug development
Anti-infectives

Trade sale
2003

Genome Therapeutics

ICAgen

Drug development
Neurology / Inflammation

IPO
2004

NASDAQ

Infinity Pharmaceuticals

Drug development
Oncology

IPO
2006

NASDAQ

Mediservice

Services
Pharmacy

Trade sale
2007

Galenica

Micromet

Drug development
Oncology

IPO
2006

NASDAQ

Newron Pharmaceuticals

Drug development
Neurology

IPO
2006

SIX

Panomics

Life science technology
Assays

Trade sale
2008

Affymetrix

Renovis

Drug development
Neurology

IPO
2003

NASDAQ

Sunesis Pharmaceuticals

Drug development
Oncology

IPO
2005

NASDAQ

Syrrx

Drug discovery
Metabolic

Trade sale
2005

Takeda

Transform Pharmaceuticals

Drug manufacturing
Formulations

Trade sale
2005

Johnson &
Johnson

Xenoport

Drug development
Neurology

IPO
2005

NASDAQ

Zycos

Drug development
Anti-infectives / Oncology

Trade sale
2004

MGI Pharma